Iversen L |
Pharmacology. Endogenous cannabinoids. |
1994 |
Nature |
pmid:7990950
|
Schwarz H et al. |
Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. |
1994 |
J. Neuroimmunol. |
pmid:7962480
|
Devane WA and Axelrod J |
Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:8022836
|
Wickens AP and Pertwee RG |
delta 9-Tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats. |
1993 |
Eur. J. Pharmacol. |
pmid:8119321
|
Pertwee RG et al. |
Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. |
1993 |
Br. J. Pharmacol. |
pmid:8306090
|
Mackie K et al. |
Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. |
1993 |
Mol. Pharmacol. |
pmid:8371711
|
Felder CC et al. |
Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. |
1993 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:8395053
|
Iversen LL |
Pharmacology. Medical uses of marijuana? |
1993 |
Nature |
pmid:8395659
|
Vogel Z et al. |
Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. |
1993 |
J. Neurochem. |
pmid:8515284
|
Crawley JN et al. |
Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. |
1993 |
Pharmacol. Biochem. Behav. |
pmid:7906042
|